Status:

UNKNOWN

Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients

Lead Sponsor:

Central Hospital, Nancy, France

Conditions:

NAFLD

Type 2 Diabetes

Eligibility:

All Genders

18+ years

Brief Summary

Non Alcoholic Fatty Liver Disease (NAFLD) is an emergent disease worldwide, and soon the leading cause of hepatic transplant in the USA. Among this high number of patients, the current challenge is to...

Eligibility Criteria

Inclusion

  • Type 2 diabetes mellitus
  • Patients who had undergone a VCTE examen at Universitary Hospital of Nancy between January 1st, 2014 and December 31th, 2019
  • \- Patients who had undergone a DEXA at Universitary Hospital of Nancy with less than one year of difference with VCTE

Exclusion

  • Viral, ethylic, drug-linked, genetic, self-immune hepatitis, liver cancer or metatasis ; other causes who could interact with fibroscan or biological markers (thrombocytopenia, undernutrition)
  • Type 1 diabetes mellitus
  • Weight variation (\>5% of body weight) between DEXA mesure and Fibroscan mesure
  • Fail of VCTE examination
  • High alcohol consumption (\>30g/day for men and \>20g.day for women)
  • Pregnant women
  • Other causes of secondary hepatic steatosis (drug-linked, parenteral nutrition, rare diseases...)
  • Any other pathology that the investigator would consider not compatible with the research
  • Patients in any other research protocol three months before inclusion
  • Person referred as in the Public Health code (articles L.1121-5, L.1121-7 and L.1121-8) : pregnant or nursing woman, minor adult, major adult under legal protection, adult unable of giving consent
  • Person deprived of their liberty by judicial or administrative decision, person under psychiatric care as described in articles L. 3212-1 and L.3213-1.

Key Trial Info

Start Date :

July 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2020

Estimated Enrollment :

86 Patients enrolled

Trial Details

Trial ID

NCT04493814

Start Date

July 1 2020

End Date

August 1 2020

Last Update

July 30 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

GUERCI Bruno

Nancy, France, 54500